Results 231 to 240 of about 4,840,656 (302)
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Short-term effects of video-based education on occupational safety knowledge among commercial divers. [PDF]
Nishikiori H, Ishitake T.
europepmc +1 more source
Investigating the impact of migraine on short-term and working memory: a systematic review and meta-analysis. [PDF]
McKay K, Kelly K.
europepmc +1 more source
Short-term clinical outcomes of balloon-assisted thrombectomy for acute middle cerebral artery occlusive. [PDF]
Liao B +14 more
europepmc +1 more source
The Ross Renaissance: Trends and Short-Term Outcomes of the Ross Procedure in the United States. [PDF]
Vadlakonda A +6 more
europepmc +1 more source
Short-Term Changes in Retinal Activity With Four Myopia Control Spectacle Lenses. [PDF]
Fernandes P +3 more
europepmc +1 more source
Tax certainty: proposals for the short term and the long term
Santiago Díaz de Sarralde +3 more
doaj
Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress.
Grill JD +18 more
europepmc +1 more source

